We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Medical Imaging Health IT Point of Care Business Focus

Medison to Launch Two New Advanced Ultrasound Systems

By HospiMedica staff writers
Posted on 17 Feb 2003
On the threshold of introducing two new ultrasound systems in 2003, Medison Co., Ltd. (Seoul, Korea) has announced the specifications for these systems, including the new technology and other advanced features that will be incorporated in them.

The Accuvix QV, which stands for "Accurate Vision, Accurate Diagnosis,” is being heralded by Medison as the most technologically advanced ultrasound system the company has ever built. The system, now undergoing final testing, features 1024 channel digital beam-forming technology and frequency compound imaging, providing superior spatial and contrast resolution.

The system also features Live 3D imaging (also known as 4D technology) to show moving organs in real-time. Use is enhanced by an intuitive control layout and easy access to operating menus. The system features the world's first 3D mouse controller, says Medison. This enables the user to freely control and manipulate scanned images in real-time.

The SonoAce Pico is an all-new color digital portable ultrasound system, designed for doctors practicing in obstetrics/gynecology, internal medicine, or radiology. About the size of a regular business briefcase, the system delivers images that are on par with those obtained from higher-class systems. The SonoAce Pico features digital beam-forming and harmonic imaging technologies, and includes spectral and color Doppler. Maintenance and upgrades can all be performed through remote service by an Internet connection. A wide selection of probes are offered. "The introduction of these advanced systems will further enhance Medison's reputation as a technology leader around the world”, said M.T. Kwon, director of Medison's International Division.


Related Links:
Medison
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Medical Examination & Procedure Light
Vega 80
Desk Aneroid Sphyg
Diagnostix 750D+

Channels

Critical Care

view channel
Image: Masimo smartSET pulse oximetry with PPG AFib and OIRD Detection (Photo courtesy of Masimo)

Smart Pulse Oximetry Supports Earlier Recognition of Arrhythmias and Respiratory Risk

On general care floors, respiratory compromise and arrhythmias can develop between routine checks. Atrial fibrillation often goes undiagnosed in older adults, while opioid-induced respiratory depression... Read more

Patient Care

view channel
Image: Researchers evaluated the Omni 128 cm long-axial field-of-view PET/CT system, which captures more of the body and radiotracer signal at once, potentially enabling shorter scans. (Photo courtesy of GE HealthCare)

Total-Body PET/CT Scanner Enables One-Minute Diagnostic-Quality Cancer Imaging

Positron emission tomography/computed tomography (PET/CT) combines radiotracer-based functional imaging with anatomical detail to diagnose, stage, and monitor cancer. Conventional scanners image the body... Read more

Medical Imaging

view channel
Image: Visual Abstract (Sinuo Gao, Zhaoqi Zhang, Chao Shi, Cheng Cheng, Xindi Ma, Xinming Zhao, Yunjiang Liu Journal of Nuclear Medicine Oct 2026, 67 (10) 1552-1559; DOI: 10.2967/jnumed.125.271529)

Targeted PET/CT Predicts Early Treatment Response in HER2-Positive Breast Cancer

HER2-positive breast cancer is an aggressive subtype that accounts for a substantial proportion of breast cancer cases. Patients often receive neoadjuvant therapy before surgery to shrink tumors, but assessing... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more